Delcath Systems Inc (DCTH)

[jlee3]

Updated phase 2's:

Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC

https://clinicaltrials.gov/ct2/show/NCT02406508?term=NCT+02406508&rank=1

Study Start Date: October 2014
Estimated Study Completion Date: September 2017
Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)


Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma

https://clinicaltrials.gov/ct2/show/NCT02415036?term=NCT+02415036&rank=1

Study Start Date: June 2014
Estimated Study Completion Date: February 2018
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)